newsfilter
← Latest News
GlobeNewswire·

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025

EQ

LA JOLLA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe